drugset / Trial / NCT02500628

Heart Rate Variability in Response to Metformin Challenge

NCT02500628 ↗

Phase 2 Completed 61 enrolled Woodinville Psychiatric Associates
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

Diseases caused by brain energy supply defects can be innate (fibromyalgia secondary to familial mitochondrial disorders) or acquired (tardive dyskinesia or weight gain associated with prolonged antipsychotic use). Patients with these possible mitochondrial disorders will provide a baseline resting heart rate sample, ingest low-dose metformin (500 mg), and then provide an additional sample 2 hours later.

Timeline

Start
2015-07
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Background Metformin Small molecule 500 mg Oral